vs
CASTLE BIOSCIENCES INC（CSTL）与Riley Exploration Permian, Inc.（REPX）财务数据对比。点击上方公司名可切换其他公司
Riley Exploration Permian, Inc.的季度营收约是CASTLE BIOSCIENCES INC的1.4倍（$113.9M vs $83.7M），CASTLE BIOSCIENCES INC净利率更高（-17.4% vs -61.8%，领先44.5%），Riley Exploration Permian, Inc.同比增速更快（11.2% vs -4.9%），过去两年Riley Exploration Permian, Inc.的营收复合增速更高（3.9% vs -1.9%）
Castle Biosciences是一家处于商业阶段的诊断企业，专注于开发和商业化针对黑色素瘤等皮肤癌及罕见病的专利临床诊断检测产品，主要服务美国医疗市场，聚焦未被满足的精准诊断需求领域，辅助临床医生制定治疗决策。
Riley Exploration Permian, Inc.是一家独立能源企业，专注于美国得克萨斯州与新墨西哥州境内的二叠纪盆地，开展原油、天然气及天然气凝析液的勘探、开发与生产业务，主打低成本陆上储备开发，为北美市场供应稳定能源产品。
CSTL vs REPX — 直观对比
营收规模更大
REPX
是对方的1.4倍
$83.7M
营收增速更快
REPX
高出16.0%
-4.9%
净利率更高
CSTL
高出44.5%
-61.8%
两年增速更快
REPX
近两年复合增速
-1.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $83.7M | $113.9M |
| 净利润 | $-14.5M | $-70.4M |
| 毛利率 | — | — |
| 营业利润率 | — | 38.3% |
| 净利率 | -17.4% | -61.8% |
| 营收同比 | -4.9% | 11.2% |
| 净利润同比 | 43.8% | — |
| 每股收益（稀释后） | $-0.49 | $-3.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSTLREPX
| Q1 26 | $83.7M | $113.9M | ||
| Q4 25 | $87.0M | $97.3M | ||
| Q3 25 | $83.0M | $106.9M | ||
| Q2 25 | $86.2M | $85.4M | ||
| Q1 25 | $88.0M | $102.5M | ||
| Q4 24 | $86.3M | $102.7M | ||
| Q3 24 | $85.8M | $102.3M | ||
| Q2 24 | $87.0M | $105.4M |
净利润CSTLREPX
| Q1 26 | $-14.5M | $-70.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | $-501.0K | $16.3M | ||
| Q2 25 | $4.5M | $30.5M | ||
| Q1 25 | $-25.8M | $28.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.3M | $25.7M | ||
| Q2 24 | $8.9M | $33.5M |
毛利率CSTLREPX
| Q1 26 | — | — | ||
| Q4 25 | 79.0% | — | ||
| Q3 25 | 77.5% | — | ||
| Q2 25 | 79.5% | — | ||
| Q1 25 | 81.4% | — | ||
| Q4 24 | 81.3% | — | ||
| Q3 24 | 81.8% | — | ||
| Q2 24 | 83.3% | — |
营业利润率CSTLREPX
| Q1 26 | — | 38.3% | ||
| Q4 25 | -4.4% | 26.9% | ||
| Q3 25 | -8.2% | 27.0% | ||
| Q2 25 | -4.9% | 33.7% | ||
| Q1 25 | -31.7% | 48.3% | ||
| Q4 24 | 4.7% | 31.2% | ||
| Q3 24 | 5.9% | 17.1% | ||
| Q2 24 | 5.8% | 50.9% |
净利率CSTLREPX
| Q1 26 | -17.4% | -61.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.6% | 15.3% | ||
| Q2 25 | 5.2% | 35.7% | ||
| Q1 25 | -29.4% | 27.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.6% | 25.1% | ||
| Q2 24 | 10.3% | 31.8% |
每股收益（稀释后）CSTLREPX
| Q1 26 | $-0.49 | $-3.38 | ||
| Q4 25 | $-0.06 | $4.02 | ||
| Q3 25 | $-0.02 | $0.77 | ||
| Q2 25 | $0.15 | $1.44 | ||
| Q1 25 | $-0.90 | $1.36 | ||
| Q4 24 | $0.32 | $0.52 | ||
| Q3 24 | $0.08 | $1.21 | ||
| Q2 24 | $0.31 | $1.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.8M | — |
| 总债务越低越好 | $10.1M | $240.7M |
| 股东权益账面价值 | $461.4M | $553.4M |
| 总资产 | $547.8M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.43× |
8季度趋势，按日历期对齐
现金及短期投资CSTLREPX
| Q1 26 | $63.8M | — | ||
| Q4 25 | $299.5M | — | ||
| Q3 25 | $287.5M | — | ||
| Q2 25 | $275.9M | — | ||
| Q1 25 | $275.2M | — | ||
| Q4 24 | $293.1M | — | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $85.6M | — |
总债务CSTLREPX
| Q1 26 | $10.1M | $240.7M | ||
| Q4 25 | $10.1M | $247.9M | ||
| Q3 25 | $10.0M | $367.0M | ||
| Q2 25 | $10.0M | $275.2M | ||
| Q1 25 | $10.0M | $249.3M | ||
| Q4 24 | $10.0M | $269.5M | ||
| Q3 24 | $10.0M | $288.6M | ||
| Q2 24 | $10.0M | $322.7M |
股东权益CSTLREPX
| Q1 26 | $461.4M | $553.4M | ||
| Q4 25 | $470.9M | $634.2M | ||
| Q3 25 | $467.0M | $566.5M | ||
| Q2 25 | $455.4M | $556.9M | ||
| Q1 25 | $440.3M | $532.4M | ||
| Q4 24 | $455.8M | $510.6M | ||
| Q3 24 | $441.1M | $507.4M | ||
| Q2 24 | $423.9M | $489.0M |
总资产CSTLREPX
| Q1 26 | $547.8M | $1.2B | ||
| Q4 25 | $578.6M | $1.2B | ||
| Q3 25 | $562.8M | $1.2B | ||
| Q2 25 | $544.7M | $1.0B | ||
| Q1 25 | $501.7M | $994.9M | ||
| Q4 24 | $531.2M | $993.5M | ||
| Q3 24 | $514.6M | $997.9M | ||
| Q2 24 | $487.3M | $1.0B |
负债/权益比CSTLREPX
| Q1 26 | 0.02× | 0.43× | ||
| Q4 25 | 0.02× | 0.39× | ||
| Q3 25 | 0.02× | 0.65× | ||
| Q2 25 | 0.02× | 0.49× | ||
| Q1 25 | 0.02× | 0.47× | ||
| Q4 24 | 0.02× | 0.53× | ||
| Q3 24 | 0.02× | 0.57× | ||
| Q2 24 | 0.02× | 0.66× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $47.2M |
| 自由现金流经营现金流 - 资本支出 | — | $24.6M |
| 自由现金流率自由现金流/营收 | — | 21.6% |
| 资本支出强度资本支出/营收 | — | 41.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CSTLREPX
| Q1 26 | $-22.1M | $47.2M | ||
| Q4 25 | $26.9M | $64.9M | ||
| Q3 25 | $22.6M | $63.6M | ||
| Q2 25 | $20.8M | $33.6M | ||
| Q1 25 | $-6.0M | $50.4M | ||
| Q4 24 | $24.4M | $66.4M | ||
| Q3 24 | $23.3M | $72.1M | ||
| Q2 24 | $24.0M | $51.6M |
自由现金流CSTLREPX
| Q1 26 | — | $24.6M | ||
| Q4 25 | $19.7M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | $11.6M | — | ||
| Q1 25 | $-10.8M | — | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $17.0M | — | ||
| Q2 24 | $18.8M | — |
自由现金流率CSTLREPX
| Q1 26 | — | 21.6% | ||
| Q4 25 | 22.7% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | -12.2% | — | ||
| Q4 24 | 19.5% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 21.6% | — |
资本支出强度CSTLREPX
| Q1 26 | — | 41.3% | ||
| Q4 25 | 8.3% | — | ||
| Q3 25 | 17.9% | — | ||
| Q2 25 | 10.7% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 8.8% | — | ||
| Q3 24 | 7.4% | — | ||
| Q2 24 | 6.0% | — |
现金转化率CSTLREPX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 3.90× | ||
| Q2 25 | 4.60× | 1.10× | ||
| Q1 25 | — | 1.76× | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.29× | 2.81× | ||
| Q2 24 | 2.69× | 1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
